Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Diana Gonzalez-Bermejo"'
Autor:
Carlos E. Durán, Judit Riera-Arnau, Shahab Abtahi, Romin Pajouheshnia, Vjola Hoxhaj, Magdalena Gamba, Ema Alsina, Mar Martin-Perez, Patricia Garcia-Poza, Ana Llorente-Garcia, Diana Gonzalez-Bermejo, Luisa Ibánez, Mònica Sabaté, Xavier Vidal, Elena Ballarín, Gabriel Sanfélix-Gimeno, Clara Rodríguez-Bernal, Salvador Peiró, Aníbal García-Sempere, Francisco Sanchez-Saez, Valentina Ientile, Ylenia Ingrasciotta, Claudio Guarneri, Matilde Tanaglia, Michele Tari, Ron Herings, Eline Houben, Karin Swart-Polinder, Emily Holthuis, Consuelo Huerta, Rosa Gini, Giuseppe Roberto, Claudia Bartolini, Olga Paoletti, Giorgio Limoncella, Anna Girardi, Giulia Hyeraci, Morten Andersen, Sarah Brøgger Kristiansen, Christine Erikstrup Hallgreen, Olaf Klungel, Miriam Sturkenboom
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: In March 2018, the European pregnancy prevention programme for oral retinoids was updated as part of risk minimisation measures (RMM), emphasising their contraindication in pregnant women.Objective: To measure the impact of the 2018 revis
Externí odkaz:
https://doaj.org/article/97c75f28f2b14a79838ac1ce448b894e
Autor:
Ferrán Catalá-López, Diego Macías Saint-Gerons, Diana González-Bermejo, Giuseppe M Rosano, Barry R Davis, Manuel Ridao, Abel Zaragoza, Dolores Montero-Corominas, Aurelio Tobías, César de la Fuente-Honrubia, Rafael Tabarés-Seisdedos, Brian Hutton
Publikováno v:
PLoS Medicine, Vol 13, Iss 3, p e1001971 (2016)
BackgroundMedications aimed at inhibiting the renin-angiotensin system (RAS) have been used extensively for preventing cardiovascular and renal complications in patients with diabetes, but data that compare their clinical effectiveness are limited. W
Externí odkaz:
https://doaj.org/article/cb0fbec97c0c4a97b964cd1d790684be